Oligomer-specific amyloid beta epitope and antibodies

Details for Australian Patent Application No. 2011223456 (hide)

Owner The University of British Columbia

Inventors Cashman, Neil R.

Agent Spruson & Ferguson

Pub. Number AU-A-2011223456

PCT Pub. Number WO2011/106885

Priority 61/310,167 03.03.10 US

Filing date 3 March 2011

Wipo publication date 9 September 2011

International Classifications

C07K 14/47 Peptides having more than 20 amino acids

A61K 39/00 Medicinal preparations containing antigens or antibodies

A61K 39/395 Medicinal preparations containing antigens or antibodies - Antibodies

A61P 25/28 Drugs for disorders of the nervous system

A61P 37/04 Drugs for immunological or allergic disorders

C07K 16/18 Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C12N 15/13 Mutation or genetic engineering - Immunoglobulins

G01N 33/53 Investigating or analysing materials by specific methods not covered by groups - Immunoassay

Event Publications

18 October 2012 PCT application entered the National Phase

  PCT publication WO2011/106885 Priority application(s): WO2011/106885

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011223463-UV associated mtDNA fusion transcripts and methods and uses thereof

2011223452-Radar system and method of manufacturing same